Introduction Erector spinae plane (ESP) block is an emerging interfascial block with a wide range of indications for perioperative analgesia and chronic pain treatment. Recent studies have focused their attention on mechanisms of action of ESP block. However, the pharmacokinetics of drugs injected in ESP is, as of now, uninvestigated. The aim of this brief report is to investigate the pharmacokinetics of lidocaine in a series of 10 patients.Methods We are reporting a case series of 10 patients undergoing bilateral ESP block for multilevel lumbar spine surgery. ESP was performed with 3.5 mg/kg of lidocaine based on ideal body weight. Lidocaine concentration was dosed at 5, 15, 30 min and at 1, 2 and 3 hours.Results T-max was 5 min for all the patients. C-max ranged from 1.2 to 3.8 mg/L (mean: 2.59 mg/L). AUC(0-3) was high (76%, on average) suggesting an almost complete bioavailability. Age had a negative correlation with T 1/2 of lidocaine.Conclusions Lidocaine pharmacokinetic after ESP block is well-described by a two-compartment model with a rapid and extensive rate of absorption. Nevertheless, its peak concentrations never exceeded the accepted toxicity limit. Elimination half-life was slightly prolonged, probably due to the advanced age of some patients.

Pharmacokinetics of lidocaine after bilateral ESP block

De Cassai, Alessandro;Bonanno, Claudio;Padrini, Roberto;Geraldini, Federico;Boscolo, Annalisa;Navalesi, Paolo;Munari, Marina
2021

Abstract

Introduction Erector spinae plane (ESP) block is an emerging interfascial block with a wide range of indications for perioperative analgesia and chronic pain treatment. Recent studies have focused their attention on mechanisms of action of ESP block. However, the pharmacokinetics of drugs injected in ESP is, as of now, uninvestigated. The aim of this brief report is to investigate the pharmacokinetics of lidocaine in a series of 10 patients.Methods We are reporting a case series of 10 patients undergoing bilateral ESP block for multilevel lumbar spine surgery. ESP was performed with 3.5 mg/kg of lidocaine based on ideal body weight. Lidocaine concentration was dosed at 5, 15, 30 min and at 1, 2 and 3 hours.Results T-max was 5 min for all the patients. C-max ranged from 1.2 to 3.8 mg/L (mean: 2.59 mg/L). AUC(0-3) was high (76%, on average) suggesting an almost complete bioavailability. Age had a negative correlation with T 1/2 of lidocaine.Conclusions Lidocaine pharmacokinetic after ESP block is well-described by a two-compartment model with a rapid and extensive rate of absorption. Nevertheless, its peak concentrations never exceeded the accepted toxicity limit. Elimination half-life was slightly prolonged, probably due to the advanced age of some patients.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3459672
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 19
social impact